Skip to main content

AOD-9604

Also known as: AOD 9604, AOD9604, hGH fragment 176-191, hGH fragment 177-191, Tyr-hGH 177-191

Classification

Peptide

Regulatory Status

not-established

Sources

2

Review

n/a

Overview

AOD-9604 is a synthetic peptide corresponding to a C-terminal fragment of human growth hormone, studied historically for lipolytic/metabolic effects without classical GH growth-promoting activity. Clinical development for obesity did not yield an approved product.

Evidence and limitations

Human/preclinical evidence breakdown is not available in this record.

Pathways

lipid-metabolism-researchhGH fragment peptidemetabolic research

not fully established in approved labeling

Interactions & cautions

other growth-hormone axis agents (GH, GHRH analogs, ghrelin mimetics) — No specific labeled interaction table; overlapping metabolic and endocrine experimental use is a practical caution. (review)

These are observational flags for review, not individualized instructions.

Sources

Educational reference only — not medical advice.

What people report (anecdote)

CLINICAL DATA (from trials)

Adverse events:

None recorded in our sources.

Effects measured:

Human trials: none found.

ANECDOTE

What people report: anecdote, not evidence

Loading…

Submit a claim you saw
AOD-9604: what the evidence actually says | BioStack